NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

Nanobiotix Partners with the Providence Cancer Institute to Run Immunotherapeutic Preclinical Research in Pancreatic Cancers

  • Written by ACN Newswire

image

Paris, France and Cambridge, Massachusetts, USA, Jan 11, 2018 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced it will begin a pre-clinical collaboration with Providence Cancer Institute to study Nanobiotix's lead...

Read more: Nanobiotix Partners with the Providence Cancer Institute to Run Immunotherapeutic Preclinical...